Argenica Therapeutics LtdASX: AGN

Sentinel Subjects Dosed in Second Cohort of Phase 1 Trial

Nov 7, 2022 at 2:42 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment